(1R,3S)-N-(4-(benzo[d]oxazol-2-yl)phenyl)-3-(3-ethylureido)-N-methylcyclopentanecarboxamide

ID: ALA1834196

Chembl Id: CHEMBL1834196

PubChem CID: 56678755

Max Phase: Preclinical

Molecular Formula: C23H26N4O3

Molecular Weight: 406.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCNC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1

Standard InChI:  InChI=1S/C23H26N4O3/c1-3-24-23(29)25-17-11-8-16(14-17)22(28)27(2)18-12-9-15(10-13-18)21-26-19-6-4-5-7-20(19)30-21/h4-7,9-10,12-13,16-17H,3,8,11,14H2,1-2H3,(H2,24,25,29)/t16-,17+/m1/s1

Standard InChI Key:  QMMKTTMNMBWFNU-SJORKVTESA-N

Associated Targets(Human)

FASN Tchem Fatty acid synthase (3390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 406.49Molecular Weight (Monoisotopic): 406.2005AlogP: 3.95#Rotatable Bonds: 5
Polar Surface Area: 87.47Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.20CX LogP: 2.69CX LogD: 2.69
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.67Np Likeness Score: -1.67

References

1. Kley JT, Mack J, Hamilton B, Scheuerer S, Redemann N..  (2011)  Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.,  21  (19): [PMID:21873051] [10.1016/j.bmcl.2011.07.083]
2.  (2017)  Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use,